Premature Birth Diagnostic Test Kits Market Analysis, Status and Business Outlook 2022 to 2027 – Hunter Women’s Chronicle
Reading time:2 minutes, 51 seconds
This report provides a comprehensive analysis of the Global Preterm Birth Diagnostic Test Kits Market with market size, industry forecasts and company profiles globally. The research includes:
- An overview of the key drivers and restraints in this market.
- Its impact on the rest of the healthcare market.
- Each region’s legislation for preterm birth testing.
Click on the tab below to benefit from the sample copy of the report
Sample request
Scope of the diagnostic kits market
The report contains the diagnostic kits market analysis at global and regional level. It also includes an overview of key players and focuses on their strategies, product portfolios, upcoming launches, SWOT analysis and market share.
Market size
The Premature Birth Diagnostic Kits Market is expected to reach USD 1,773.0 Million by 2022, registering a CAGR of 8.2% during the forecast period. Global Preterm Birth Diagnostic Kits Market was valued at USD 799.7 Million in 2014 and is projected to reach USD 4,478.2 Million by 2027, growing at a CAGR of 6.4% from 2016 to 2027 The increasing incidence of premature births globally is the major driver for the growth of this market.
Industry trends
The Preterm Birth Diagnostic Test Kits Market is expected to grow from USD 6.57 Billion in 2018 to USD 10.54 Billion by 2027, at a compound annual growth rate (CAGR) of 8.52%. As a result, the global preterm birth diagnostic kits market size is expected to reach USD 3,677.6 million by 2027, from USD 2,822.6 million in 2017, growing at a CAGR of 4.4% in during the forecast period.
Key players
Key players in the Preterm Birth Diagnostic Test Kit market are F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc. and Becton, Dickinson, and Company. Detecting or predicting preterm labor is an essential issue for pregnant women. Many different tests are available on the market to detect or predict preterm labor, but many of them are expensive and not covered by insurance companies. As a result, the global preterm birth diagnostic kits market is expected to reach USD 5.75 billion by the end of 2027, growing at a CAGR of 9.6% during the forecast period.
Competitive analysis
The market is expected to reach $1,049.5 million by the end of 2022, growing at a CAGR of 8.50% from 2017 to 2027. North America dominates the global market owing to its large population. Moreover, this region is expected to have the highest demand during the forecast period owing to its high prevalence rate of complications in premature births.
Forecasts and trends
The prenatal diagnostic test kits market, which is expected to grow at a CAGR of 9.2%, has seen good traction from 2016. The growing need for preconception testing has driven the growth of this market. Additionally, the rising prevalence of planned pregnancies among women coupled with out-of-cohort infertility are some of the critical factors that have propelled this market in recent years.
Click on the tab below for the instant purchase of the report with a flat rate discount of $500
Instant Buy Request
Conclusion
Several players characterize the global preterm birth diagnostic test kits market. The competitive landscape is expected to be highly charged during the forecast period owing to the increasing adoption of prenatal diagnosis.
Comments are closed.